Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

gastrointestinal · Mechanism Report

Does increased intestinal permeability drive a self-perpetuating cycle of sIgA-driven inflammation and dysbiosis?

Increased intestinal permeability permits antigen translocation that triggers sustained secretory IgA production, chronic mucosal inflammation, and a feedback loop that reinforces dysbiosis.

SupportedJune 19, 202622 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

No reasoning paths for this claim.

This is what AI claimed

When intestinal permeability increases, more microbial and food antigens cross the mucosa, which sustains secretory IgA-driven immune activation and reinforces dysbiosis by creating an inflamed gut environment.

laying out figure…
No reasoning paths
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

When tight junction integrity is lost, microbial and dietary antigens cross the mucosa and are sampled by mucosal immune cells, provoking elevated sIgA production and persistent mucosal immune activation. The resulting inflamed environment and sIgA-mediated agglutination selectively favor pathobionts, reduce SCFA production needed for epithelial repair, and perpetuate barrier dysfunction and dysbiosis.

Verified conclusion

The breakdown of the intestinal barrier, or increased intestinal permeability, initiates a self-perpetuating cycle of immune activation and microbial imbalance. This process is driven by the loss of tight junction integrity, allowing for the systemic entry of antigens that would normally be excluded.

Clinical and Mechanistic Evidence

  • Antigen Translocation: The primary driver of this cycle is the upregulation of zonulin, which triggers the disassembly of tight junction proteins like occludin and ZO-1. This allows macromolecules, including dietary proteins (e.g., gliadin) and microbial components (e.g., lipopolysaccharides), to move from the gut lumen into the lamina propria.
  • Immune Activation: Once these antigens cross the mucosa, they are sampled by M cells and presented to B cells in Peyer's patches. This process induces a significant increase in the production of secretory IgA (sIgA). While sIgA is intended to neutralize these threats via immune exclusion, chronic exposure leads to sustained mucosal immune activation.
  • Dysbiosis Reinforcement: In an inflamed environment, sIgA can paradoxically reinforce dysbiosis through "enchained growth." By agglutinating bacteria, sIgA can trap certain species in the mucus layer; under inflammatory stress, this often favors the survival of pathobionts (like Enterobacteriaceae) over beneficial obligate anaerobes (like Faecalibacterium prausnitzii).
  • The Feedback Loop: This shift toward pathobionts reduces the production of short-chain fatty acids (SCFAs), which are critical for epithelial repair and tight junction stability. The resulting inflammation and barrier damage ensure a continuous influx of antigens, keeping the mucosal immune system in a state of high alert.

Bottom line

Increased intestinal permeability triggers a robust mucosal immune response characterized by elevated sIgA. While protective in the short term, the resulting chronic inflammation and selective pressure on the microbiome create a feedback loop that reinforces dysbiosis and prevents the restoration of a healthy gut barrier.

References

  1. Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability — gut.bmj.com ↗
  2. Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. — pmc.ncbi.nlm.nih.gov ↗
  3. High sodium diet and intestinal permeability in young, healthy adults — journals.physiology.org ↗
  4. Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles — frontiersin.org ↗
  5. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases — pmc.ncbi.nlm.nih.gov ↗
  6. Antigen sampling by intestinal M cells is the principal pathway initiating mucosal IgA production to commensal enteric bacteria — linkinghub.elsevier.com ↗
  7. The Underappreciated Role of Secretory IgA in IBD. — academic.oup.com ↗
  8. Secretory IgA: Designed for Anti-Microbial Defense — frontiersin.org ↗
  9. Growing, evolving and sticking in a flowing environment: understanding IgA interactions with bacteria in the gut — pmc.ncbi.nlm.nih.gov ↗
  10. Secretory IgA in breast milk protects against asthma through modulation of the gut microbiota. — linkinghub.elsevier.com ↗
  11. The impact of the Th17:Treg axis on the IgA-Biome across the glycemic spectrum — pmc.ncbi.nlm.nih.gov ↗
  12. Faecalibacterium prausnitzii enhances intestinal IgA response by host-microbe derived inecalcitol in colitis — bmcmedicine.biomedcentral.com ↗
  13. Secretory IgA dysfunction underlies poor prognosis in Fusobacterium-infected colorectal cancer — tandfonline.com ↗
  14. IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1 via the TLR4 signaling pathway — pmc.ncbi.nlm.nih.gov ↗
  15. Apyrase-mediated amplification of secretory IgA promotes intestinal homeostasis. — ssrn.com ↗
  16. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases — tandfonline.com ↗
  17. Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson’s Disease — frontiersin.org ↗
  18. Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. — pmc.ncbi.nlm.nih.gov ↗
  19. Parallelism of intestinal secretory IgA shapes functional microbial fitness — nature.com ↗
  20. Cooperativity among secretory IgA, the polymeric immunoglobulin receptor, and the gut microbiota promotes host-microbial mutualism. — pmc.ncbi.nlm.nih.gov ↗
  21. Roles of Secretory Immunoglobulin A in Host-Microbiota Interactions in the Gut Ecosystem — pmc.ncbi.nlm.nih.gov ↗
  22. Plasma-Derived Polyreactive Secretory-Like IgA and IgM Opsonizing Salmonella enterica Typhimurium Reduces Invasion and Gut Tissue Inflammation through Agglutination — journal.frontiersin.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Unsupported12 sourcesCan reflux reaching the larynx and pharynx irritate upper-airway mucosa and relate to chronic rhinosinusitis?→Plausible11 sourcesDoes BabA-positive Helicobacter pylori bind gastric epithelial Lewis b antigens and promote inflammation?→